4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000057
Options or other derivatives
- Chief Technology Officer acquired 7,269.97 shares (option exercise)
- Chief Technology Officer acquired 242,328 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kurtoglu Metin · Chief Technology Officer
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-08 | Exercise or conversion : show line 1 in the form Stock Option (Right to Buy) | −6,414.68 | 0 | D |
| 2024-04-08 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | +213,820 | 213,820 | D |
| 2024-04-08 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −427.65 | 0 | D |
| 2024-04-08 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | +14,254 | 14,254 | D |
| 2024-04-08 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −427.65 | 0 | D |
| 2024-04-08 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | +14,254 | 14,254 | D |
Loading xslF345X05/wk-form4_1712799040.xml…